Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Wound care division will "phase out production and marketing of selected general wound care product lines - including eye pads, sponges, gauze pads, tapes and cleaners - in the U.S. within the next six months," firm says in July 1 letter to distributors. J&J/Ethicon instead will focus on developing drug/device combination products for advanced wound care, such as Band-Aid liquid bandage and Dermabond topical skin adhesive, which are manufactured by Closure Medical and marketed by J&J (1"The Tan Sheet" March 18, 2002, p. 19). Several Band-Aid products, such as Steri-Pad gauze pads, are affected by the phase-out, which includes 36 brands. J&J/Ethicon plans to close its manufacturing facility in Sherman, Texas by Dec. 31 and says the move will affect roughly 510 employees at the plant...

You may also be interested in...

J&J Band-Aid Liquid Bandage Labeling Stresses “Fast Healing” Benefits

Band-Aid Liquid Bandage is reaching food, drug and mass shelves now after shipping in late February, according to Johnson & Johnson Consumer Products

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts